Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support... see more

PINL:GRPOF - Post Discussion

Traxion Sab De Cv Ord Shs > NAMASTE & TETRA SUPPLY AGREEMENT
View:
Post by Stocknovice101 on May 17, 2018 8:38am

NAMASTE & TETRA SUPPLY AGREEMENT

Namaste Announces Medical Cannabis Supply Agreement with Tetra Natural Health, to Sell RX Princeps Through Cannmart
Namaste Technologies Inc.
MAY 17 18 /08:30 ET
VANCOUVER, May 17, 2018 /CNW/ - Namaste Technologies Inc. ("Namaste" or the "Company") (TSXV: N)(FRA: M5BQ)(OTCMKTS: NXTTF) is pleased to announce that the Company has signed a Supply Agreement (the "Supply Agreement") for the sale and distribution of RX Princeps the medicinal marijuana brand of Tetra Natural Health, a division of Tetra Bio-Pharma  ("Tetra Bio-Pharma")(TSXV: TBP)(OTCQB: TBPMF), whereby Namaste will purchase RX Princeps  from Tetra Natural Health  which will be sold through Namaste's wholly owned subsidiary and Access to Cannabis for Medical Purposes ("ACMPR") medical cannabis "sales-only" facility, Cannmart Inc. ("Cannmart"). In anticipation of receiving Cannmart's sales license, the Company is focused on procuring cannabis from strategic partners to offer through its platform.  
 
Tetra Bio-Pharma is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a clinical program aimed at bringing novel drugs and treatments to patients and their healthcare providers. In anticipation of receiving its sales license, Namaste is now focused on ramping up inventory purchasing of a carefully curated selection of high-quality medical cannabis products that will bring value to its patients.

Rx Princeps™ is a unique blend of 3 strains of medical cannabis. Its production has been standardized in order to ensure a lot-to-lot consistent composition in its active ingredients (THC and CBD).
The Supply agreement further supports Namaste's initiative to provide Cannmart's patients with the highest quality medical cannabis flower and oil available in the Canadian market. The Company will leverage its technology including its recent acquisition of leading AI and machine-learning provider Findify AB Inc. ("Findify") to focus on providing a personalized experience for each patient by using machine-learning algorithms. Patient care, retention and selection are core components of Namaste's strategy to set itself apart in the online retail of medical cannabis. The Company believes that it will develop into Canada's largest platform of medical cannabis patients and in offering an incredible patient experience.
 
Management Commentary
Guy Chamberland , CEO of Tetra Bio-Pharma comments  "We are thrilled to have signed this partnership deal with Namaste who operate as an E-Commerce Medicinal Cannabis distributor with  32 sites in 20 countries, providing substantial exposure forTetra Natural Health's RX Princeps brand of medicinal marijuana.  We believe this is the making of a solid partnership with Tetra Natural Health's ability to produce a quality product combined with Namaste's far reaching sales and distribution network."
Sean Dollinger , President and CEO of Namaste comments; "We are very proud to be bringing on a strong supply partner like Tetra Bio-Pharma. RX Princeps is a unique pharma-based product that we feel will be very valuable for our patients. We have a unique opportunity to develop an exciting platform that will cater specifically to a patients' needs. We plan on being very selective in choosing which licensed producers that we will work with to ensure that our patients receive nothing but the best quality medical cannabis available. We plan on providing a single source for all things cannabis and Cannmart and NamasteMD are key components of that strategy along with securing the highest quality cannabis for our patients. We'd like to take the opportunity to thank Tetra Bio-Pharma management team for their support and look forward to a growing future together."
Comment by LeafRider on May 17, 2018 10:23am
This post has been removed in accordance with Community Policy
Comment by Hammertown87 on May 17, 2018 1:11pm
WILL APHRIS STILL SELL RX ON THEIR WEBSITE???
Comment by Hammertown87 on May 17, 2018 1:14pm
NAMASTE NEEDS TO GET THEIR LICENSE STILL IT LOOKS LIKE.
Comment by Irievibes13 on May 17, 2018 2:44pm
They already have one...Namaste Receives ACMPR Medical Cannabis Production License March 16, 2018 15:52 ET | Source: Namaste Technologies Inc.
Comment by PCR1917 on May 17, 2018 3:28pm
But namaste still does not have its sales licence.
Comment by Sweeetydi on May 17, 2018 3:38pm
Their sales license is due any Friday.  It could be tomorrow.  The decision is in Health Canada’s hands. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities